Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 29, 2018	Dec. 30, 2017
Current Assets:
Cash, cash equivalents and restricted cash	$ 6,060	$ 9,648
Trade receivables, net of allowances of $202 and $695	10,211	9,114
Prepaid expenses and other current assets	1,096	994
Costs and estimated earnings in excess of billings on uncompleted contracts	3,175	5,273
Total Current Assets	20,542	25,029
Property and Equipment, net	677	1,027
Goodwill	720	2,806
Other Assets	367	390
Total Assets	22,306	29,252
Current Liabilities:
Accounts payable	3,172	3,742
Accrued compensation and benefits	2,301	2,039
Billings in excess of costs and estimated earnings on uncompleted contracts	604	1,334
Other current liabilities	740	1,068
Total Liabilities	6,817	8,183
Commitments and Contingencies (Notes 6 and 13)
Stockholders' Equity:
Common stock - $0.001 par value; 75,000,000 shares authorized; 27,487,594 and 27,514,380 shares issued and outstanding at December 29, 2018 and December 30, 2017	27	27
Additional paid-in capital	36,934	36,843
Accumulated deficit	(21,472)	(15,801)
Total Stockholders' Equity	15,489	21,069
Total Liabilities and Stockholders' Equity	$ 22,306	$ 29,252